Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Chiang, NJ
Bin-Yea Chiang, Cedar Knolls, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100316772 | Cookie Products Having Enhanced Stability - There is provided a cookie sandwich product having enhanced stability during manufacture, the cookie sandwich product comprising a top and a bottom cookie with a filling disposed therebetween. The top and bottom cookies have an inner and outer surface, with the inner surface being substantially flat and the outer cookies comprising a plurality of outer surface portions where at least one of the outer surface portions is substantially flat and provides stability to the cookie during manufacture of the cookie sandwich. A method of providing stability to cookie products during manufacture is also provided. | 12-16-2010 |
Bryce Chiang, Somerset, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110152711 | SYSTEMS AND METHODS FOR TESTING VESTIBULAR AND OCULOMOTOR FUNCTION - The invention relates to systems and methods for testing vestibular and oculomotor function. One aspect of the invention provides a vestibular and oculomotor function testing device including a track supported by a plurality of bearings, an engine configured to selectively displace the track, and a head coupling component coupled to the track. The head coupling component is configured to convey a movement generated by the engine to a subject's head in one or more axes. | 06-23-2011 |
Chen-Huan Chiang, Princeton Junction, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090144593 | Method and apparatus for describing parallel access to a system-on-chip - The present invention provides a new hardware description language for chip-level JTAG testing. This new hardware description language, referred to as New BSDL (NSDL), enables testing resources of a system-on-chip to be described, thereby enabling the system-on-chip to be described in a manner that facilitates testing of the system-on-chip. The present invention provides a bottom-up approach to describing a system-on-chip. The present invention supports algorithmic descriptions of each of the components of the system-on-chip, and supports an algorithmic description of interconnections between the components of the system-on-chip, thereby enabling generation of an algorithmic description of the entire system-on-chip or portions of the system-on-chip. The present invention supports parallel access to one or more system-on-chip devices, including methods for describing and using parallel access for testing. | 06-04-2009 |
| 20090144594 | METHOD AND APPARATUS FOR DESCRIBING AND TESTING A SYSTEM-ON-CHIP - The present invention provides a new hardware description language for chip-level JTAG testing. This new hardware description language, referred to as New BSDL (NSDL), enables testing resources of a system-on-chip to be described, thereby enabling the system-on-chip to be described in a manner that facilitates testing of the system-on-chip. The present invention provides a bottom-up approach to describing a system-on-chip. The present invention supports algorithmic descriptions of each of the components of the system-on-chip, and supports an algorithmic description of interconnections between the components of the system-on-chip, thereby enabling generation of an algorithmic description of the entire system-on-chip or portions of the system-on-chip. | 06-04-2009 |
| 20090193304 | Apparatus and Method for Isolating Portions of a Scan Path of a System-on-Chip - The invention includes an apparatus and method for dynamically isolating a portion of a scan path of a system-on-chip. In one embodiment, an apparatus includes a scan path and control logic. The scan path includes at least a first hierarchical level, where the first hierarchical level includes a plurality of components, and a second hierarchical level having at least one component. The second hierarchical level is adapted for being selected and deselected such that the second hierarchical level is active or inactive. The control logic is adapted to filter application of at least one control signal to the at least one component of the second hierarchical level in a manner for controlling propagation of data within the second hierarchical level independent of propagation of data within the first hierarchical level. In one embodiment, when the second hierarchical level is deselected, the control logic prevents data from being propagated within the second hierarchical level while data is propagated within the first hierarchical level. In one embodiment, the second hierarchical level may be used for independent, parallel testing while data continues to be propagated through the first hierarchical level. | 07-30-2009 |
| 20090193306 | APPARATUS AND METHOD FOR CONTROLLING DYNAMIC MODIFICATION OF A SCAN PATH - The invention includes an apparatuses and associated methods for controlling dynamic modification of a testing scan path using a control scan path. In one embodiment, an apparatus includes a testing scan path and a control scan path. The testing scan path includes testing components and at least one hierarchy-enabling component. In one embodiment, the control scan path includes at least one control component coupled to the at least one hierarchy-enabling component for controlling dynamic modification of the testing scan path. In one embodiment, the control scan path includes the at least one hierarchy-enabling component, wherein the at least one hierarchy-enabling component is adapted for dynamically modifying the testing scan path using the control scan path. The dynamic modification of the testing scan path may include modifying a hierarchy of the testing scan path, such as selecting or deselecting one or more hierarchical levels of the testing scan path. | 07-30-2009 |
Chen-Huan Chiang, Princetion Junction, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090144592 | Method and Apparatus for Describing Components Adapted for Dynamically Modifying a Scan Path for System-on-Chip Testing - The present invention provides a new hardware description language for chip-level JTAG testing. This new hardware description language, referred to as New BSDL (NSDL), enables testing resources of a system-on-chip to be described, thereby enabling the system-on-chip to be described in a manner that facilitates testing of the system-on-chip. The present invention provides a bottom-up approach to describing a system-on-chip. The present invention supports algorithmic descriptions of each of the components of the system-on-chip, and supports an algorithmic description of interconnections between the components of the system-on-chip, thereby enabling generation of an algorithmic description of the entire system-on-chip or portions of the system-on-chip. The present invention supports devices adapted for dynamically modifying the scan path of a system-on-chip (referred to herein as crossroad devices), including methods for describing such devices and use of such devices to perform testing of system-on-chips. | 06-04-2009 |
Cho-Yu Jason Chiang, Clinton, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110299389 | Real Time Monitoring, Onset Detection And Control Of Congestive Phase-Transitions in Communication Networks - Systems and methods for managing network congestion through detecting the closeness to network congestion. The network includes a plurality of network nodes, where each node has at least one neighboring node and each node has a buffer for a queue of packets from other nodes. The system measures queue length at a node and the node's neighboring nodes, processes the measured queue lengths to obtain patterns of fluctuations for the measured queue length. The system determines if one or more of the measured nodes are in a transition-onset status toward a phase transition point based on the obtained patterns of fluctuation and generates congestion control signals based on the determination to route network traffic away. The phase transition point corresponds to a change from a non-congestive phase of the measured nodes to a congestive phase of the measured nodes. | 12-08-2011 |
Katherine S. Chiang, Princeton, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110042813 | PRINTED ELECTRONICS - Printed electronic device comprising a substrate onto at least one surface of which has been applied a layer of an electrically conductive ink comprising functionalized graphene sheets and at least one binder. A method of preparing printed electronic devices is further disclosed. | 02-24-2011 |
Lillian W Chiang, Princeston, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100222304 | Methods of Treating Neuropathic Pain by Modulation of Glycogenolysis or Glycolysis - Embodiments of the invention relate to the treatment of neuropathic pain in mammals. Embodiments of the invention include methods for treating neuropathic pain as well as methods for preparing medicaments used in the treatment of mammalian pain. Preferably, methods of the invention comprise the modulation of glycogeno lysis or glycolysis pathways for the treatment of mammalian pain. | 09-02-2010 |
Lillian W. Chiang, Princeton, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100076037 | Methods of Treating Neuropathic Pain with Agonists of PPAR-gamma - Embodiments of the invention relate to the treatment of neuropathic pain in mammals. Embodiments of the invention include methods for treating neuropathic pain as well as methods for preparing medicaments used in the treatment of mammalian pain. Preferably, methods of the invention comprise the use of PPARgamma agonists for the treatment of mammalian pain. | 03-25-2010 |
| 20110028527 | Methods of Treating Neuropathic Pain with Benzimidazole Derivative Agonists of PPARgamma - Embodiments of the invention relate to the treatment of neuropathic pain in mammals. Embodiments of the invention include methods for treating neuropathic pain with benzimidazole derivatives with PPARgamma agonist activity, as well as methods for preparing medicaments used in such treatments of mammalian pain. | 02-03-2011 |
Lillian Wei-Ming Chiang, Princeton, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100291099 | NOVEL 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 AND 32222 MOLECULES AND USES THEREFOR - The invention provides isolated nucleic acids molecules and proteins, designated 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 20A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 and 32222 nucleic acid molecules and proteins. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing said nucleic acid molecules, host cells into which the expression vectors have been introduced, nonhuman transgenic animals in which a said genes have been introduced or disrupted, fusion proteins, antigenic peptides and antibodies to said proteins. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided. | 11-18-2010 |
| 20110230392 | NOVEL NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, AND NARC 25 MOLECULES AND USES THEREFOR - The invention provides isolated nucleic acids molecules and proteins, designated NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, and NARC 25, nucleic acid molecules and proteins. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing said nucleic acid molecules, host cells into which the expression vectors have been introduced, nonhuman transgenic animals in which a said genes have been introduced or disrupted, fusion proteins, antigenic peptides and antibodies to said proteins. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided. | 09-22-2011 |
Lillian Wei-Ming Chiang, Edison, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090269350 | Novel 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 10A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC1C, NARC 1A, NARC 25, 86604 and 32222 molecules and uses therefor - The invention provides isolated nucleic acids molecules and proteins, designated 27411, 23413, 22438, 23553, 25278, 26212, NARC SC1, NARC 20A, NARC 1, NARC 12, NARC 13, NARC17, NARC 25, NARC 3, NARC 4, NARC 7, NARC 8, NARC 11, NARC 14A, NARC 15, NARC 16, NARC 19, NARC 20, NARC 26, NARC 27, NARC 28, NARC 30, NARC 5, NARC 6, NARC 9, NARC 10C, NARC 8B, NARC 9, NARC2A, NARC 16B, NARC 1C, NARC 1A, NARC 25, 86604 and 32222 nucleic acid molecules and proteins. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing said nucleic acid molecules, host cells into which the expression vectors have been introduced, nonhuman transgenic animals in which a said genes have been introduced or disrupted, fusion proteins, antigenic peptides and antibodies to said proteins. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided. | 10-29-2009 |
Michael Chiang, Flemington, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20090004287 | Disinfectant formulations containing quaternary ammonium compounds and hydrogen peroxide - Disinfectant compositions having at least one biocidal quaternary ammonium carbonate and/or bicarbonate and hydrogen peroxide. A method for killing or inhibiting the growth of microorganisms, algae and fungi involves applying the disinfectant compositions. Methods involving inhibiting the decomposition of aqueous hydrogen peroxide solutions and involving inhibiting the corrosive action of aqueous hydrogen peroxide on metals. | 01-01-2009 |
Wan-Ping Chiang, Colts Neck, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100097213 | SECURITY INFRASTRUCTURE - An automated security infrastructure is disclosed that includes security agents that are designed to analyze security issues. The security agents process events received from event-messages, and records data associated with a security issue in a ticket. Security and management personnel are kept informed based on notification subscription lists. Assigned security personnel's progress in resolving outstanding security issues is monitored until those issues are resolved. | 04-22-2010 |
William Chiang, Pennington, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100300896 | Redox Molecules And Methods Of Making The Same - A non-leaching mediator may include a compound having the general formula (I): | 12-02-2010 |
| 20110294959 | Polymer Bonded Redox Molecules And Methods Of Making The Same - A non-leaching mediator may include a polymer having a polymeric backbone, and a plurality of phenothiazine groups bonded to the polymeric backbone. The plurality of phenothiazine groups may include at least one of a phenothiazine group having the general formula (IV): | 12-01-2011 |
Win-Chin Chiang, Monroe, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100104696 | Nutritional Composition With Improved Digestibility - The present invention is directed an improved nutritional composition, methods of improving digestion, and methods of enhancing the bioavailability of TGF-β. | 04-29-2010 |
Yi Wen Chiang, Somerset, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20110136169 | EXPRESSION SYSTEM COMPOSITIONS AND METHODS - The present invention relates to novel expression systems and methods for preparing samples for 3D structure determination of a protein based on a protein expression vector, | 06-09-2011 |
Yulin Chiang, Convent Station, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20080200496 | SUBSTITUTED 1H-PYRROLO[3,2-b, 3,2-c, and 2,3-c]PYRIDINE-2-CARBOXAMIDES AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE Ie - The present invention discloses and claims compounds of formula (I) | 08-21-2008 |
| 20080227822 | SUBSTITUTED THIENOPYRROLE CARBOXYLIC ACID AMIDES, PYRROLOTHIAZOLE CARBOXYLIC ACID AMIDES, AND RELATED ANALOGS AS INHIBITORS OF CASEIN KINASE I - The present invention comprises methods for the treatment of central nervous system diseases and disorders including mood disorders and sleep disorders through the administration of compounds of formula (I) and formula (II) | 09-18-2008 |
| 20090247509 | Novel Heterocyclic Substituted Carbonyl Derivatives and Their Use as Dopamine D3 Receptor Ligands - The invention relates to heterocyclic substituted carbonyl derivatives that display selective binding to dopamine D | 10-01-2009 |
Yulin Chiang, Bridgewater, NJ US
| Patent application number | Description | Published |
|---|---|---|
| 20100152157 | 6-CYCLOAMINO-3-(PYRIDAZIN-4-YL)IMIDAZO[1,2-b]-PYRIDAZINE AND DERIVATIVES THEREOF PREPARATION AND THERAPEUTIC APPLICATION THEREOF - The invention relates to the 6-cycloamino-3-(pyridazin-4-yl)imidazo[I,2-b]pyridazine derivatives corresponding to general formula (I): | 06-17-2010 |